BeyondTodaysPharma

Market Insights India's biotech and pharmaceutical industries have a long-established reputation for high-quality production at competitive prices. These capabilities, combined with India's vast pool of skilled professionals, provide an ideal environment for developing and manufacturing cell therapies. The country is soon to become a global hub, leveraging its cost advantages to meet growing demand both locally and internationally. Indian companies are also increasingly forming strategic partnerships with global entities, enhancing their technological prowess and expanding market access. Furthermore, India's diverse population allows for cost-effective and wide-ranging clinical trials, offering an advantage for companies to test therapies for a variety of genetic backgrounds and diseases​ ( CGT demand ) Growth Projections According to Grand View Research, the Indian cell therapy market is projected to grow at an impressive compound annual growth rate (CAGR) of 25.3%, reachi...

At first glance, the esoteric quantum mechanics thought experiment of Schrödinger's cat and the practical world of pharmaceutical logistics may seem worlds apart. However, a closer examination reveals intriguing parallels between these seemingly disparate concepts, particularly when considering the use of temperature data loggers in drug transportation. Schrödinger's cat, proposed by physicist Erwin Schrödinger in 1935, imagines a cat in a sealed box with a flask of poison and a radioactive source. If an internal monitor detects radioactivity, the flask is shattered, releasing the poison and killing the cat. According to quantum mechanics, until the box is opened and observed, the cat exists in a superposition of states - both alive and dead simultaneously. Similarly, in pharmaceutical logistics, temperature-sensitive medications are placed in sealed, insulated containers for transport. These shipments often include temperature data loggers to monitor environmental conditions...